Cas 1286275-61-3,(S)-4-(8-cyclopropyl-9-ethyl-2-(4-nitrophenyl)-9H-purin-6-yl)-3-methylmorpholine

1286275-61-3

Post Buying Request

Basic information

Product Name: (S)-4-(8-cyclopropyl-9-ethyl-2-(4-nitrophenyl)-9H-purin-6-yl)-3-methylmorpholine
Synonyms: (S)-4-(8-cyclopropyl-9-ethyl-2-(4-nitrophenyl)-9H-purin-6-yl)-3-methylmorpholine
CAS NO:1286275-61-3
Molecular Formula:
Molecular Weight: 408.46
EINECS: N/A
Product Categories: N/A
Mol File: 1286275-61-3.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-4-(8-cyclopropyl-9-ethyl-2-(4-nitrophenyl)-9H-purin-6-yl)-3-methylmorpholine(CAS DataBase Reference)
NIST Chemistry Reference: (S)-4-(8-cyclopropyl-9-ethyl-2-(4-nitrophenyl)-9H-purin-6-yl)-3-methylmorpholine(1286275-61-3)
EPA Substance Registry System: (S)-4-(8-cyclopropyl-9-ethyl-2-(4-nitrophenyl)-9H-purin-6-yl)-3-methylmorpholine(1286275-61-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1286275-61-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1286275-61-3 Suppliers

Recommended suppliersmore

1286275-61-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1286275-61-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,6,2,7 and 5 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1286275-61:
(9*1)+(8*2)+(7*8)+(6*6)+(5*2)+(4*7)+(3*5)+(2*6)+(1*1)=183
183 % 10 = 3
So 1286275-61-3 is a valid CAS Registry Number.

1286275-61-3Upstream product

1286275-61-3Downstream Products

1286275-61-3Relevant articles and documents

N-9 SUBSTITUTED PURINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

-

Page/Page column 35, (2011/04/25)

The present invention relates to compounds of Formula I: wherein R1, R2, R3, A1, A2, A3, A4 and D have the meaning described herein. The present invention also relates to pharmac

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1286275-61-3